133 related articles for article (PubMed ID: 21710661)
21. Gene transfer of interleukin-18-binding protein attenuates cardiac allograft rejection.
Dudler J; Simeoni E; Fleury S; Li J; Pagnotta M; Pascual M; von Segesser LK; Vassalli G
Transpl Int; 2007 May; 20(5):460-6. PubMed ID: 17313449
[TBL] [Abstract][Full Text] [Related]
22. Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression.
Liu H; Liu L; Liu K; Bizargity P; Hancock WW; Visner GA
J Immunol; 2009 Jul; 183(2):1022-31. PubMed ID: 19564344
[TBL] [Abstract][Full Text] [Related]
23. Induction of indoleamine 2,3-dioxygenase in livers following hepatectomy prolongs survival of allogeneic hepatocytes after transplantation.
Lin YC; Goto S; Tateno C; Nakano T; Cheng YF; Jawan B; Kao YH; Hsu LW; Lai CY; Yoshizato K; Chen CL
Transplant Proc; 2008 Oct; 40(8):2706-8. PubMed ID: 18929841
[TBL] [Abstract][Full Text] [Related]
24. Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression.
Wobser M; Voigt H; Houben R; Eggert AO; Freiwald M; Kaemmerer U; Kaempgen E; Schrama D; Becker JC
Cancer Immunol Immunother; 2007 Jul; 56(7):1017-24. PubMed ID: 17195079
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-10 produced by recombinant adenovirus prolongs survival of cardiac allografts in rats.
David A; Chétritt J; Guillot C; Tesson L; Heslan JM; Cuturi MC; Soulillou JP; Anegon I
Gene Ther; 2000 Mar; 7(6):505-10. PubMed ID: 10757024
[TBL] [Abstract][Full Text] [Related]
26. Gene transfer of soluble interleukin-17 receptor prolongs cardiac allograft survival in a rat model.
Li J; Simeoni E; Fleury S; Dudler J; Fiorini E; Kappenberger L; von Segesser LK; Vassalli G
Eur J Cardiothorac Surg; 2006 May; 29(5):779-83. PubMed ID: 16520057
[TBL] [Abstract][Full Text] [Related]
27. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.
Wang S; Jiang J; Guan Q; Lan Z; Wang H; Nguan CY; Jevnikar AM; Du C
Transpl Immunol; 2008 May; 19(2):93-102. PubMed ID: 18503884
[TBL] [Abstract][Full Text] [Related]
28. Dynamic changes of indoleamine 2,3-dioxygenase of Kupffer cells in rat liver transplant rejection and tolerance.
Luan X; Liao W; Lai X; He Y; Liu Y; Gong J; Li J
Transplant Proc; 2012 May; 44(4):1045-7. PubMed ID: 22564621
[TBL] [Abstract][Full Text] [Related]
29. Regulation of indoleamine 2,3 dioxygenase and its role in a porcine model of acute kidney allograft rejection.
Wang Y; Merchen TD; Fang X; Lassiter R; Ho CS; Jajosky R; Kleven D; Thompson T; Mohamed E; Yu M; Waller JL; Nahman NS
J Investig Med; 2018 Dec; 66(8):1109-1117. PubMed ID: 30006478
[TBL] [Abstract][Full Text] [Related]
30. Protective effects of atorvastatin on chronic allograft nephropathy in rats.
Zhang W; Liu M; Wu Y; Zhu P; Yin C; Zhang W; Gu M
J Surg Res; 2007 Dec; 143(2):428-36. PubMed ID: 17628598
[TBL] [Abstract][Full Text] [Related]
31. Are indoleamine-2,3-dioxygenase producing human dendritic cells a tool for suppression of allogeneic T-cell responses?
Löb S; Ebner S; Wagner S; Weinreich J; Schäfer R; Königsrainer A
Transplantation; 2007 Feb; 83(4):468-73. PubMed ID: 17318080
[TBL] [Abstract][Full Text] [Related]
32. Reduced expression of indoleamine 2,3-dioxygenase participates in pathogenesis of preeclampsia via regulatory T cells.
Liu X; Liu Y; Ding M; Wang X
Mol Med Rep; 2011; 4(1):53-8. PubMed ID: 21461563
[TBL] [Abstract][Full Text] [Related]
33. Indoleamine 2, 3-Dioxgenase Transfected Mesenchymal Stem Cells Induce Kidney Allograft Tolerance by Increasing the Production and Function of Regulatory T Cells.
He Y; Zhou S; Liu H; Shen B; Zhao H; Peng K; Wu X
Transplantation; 2015 Sep; 99(9):1829-38. PubMed ID: 26308414
[TBL] [Abstract][Full Text] [Related]
34. Proapoptotic activity of indoleamine 2,3-dioxygenase expressed in renal tubular epithelial cells.
Mohib K; Guan Q; Diao H; Du C; Jevnikar AM
Am J Physiol Renal Physiol; 2007 Sep; 293(3):F801-12. PubMed ID: 17609291
[TBL] [Abstract][Full Text] [Related]
35. Modulation of cellular tryptophan metabolism in human fibroblasts by transforming growth factor-beta: selective inhibition of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase gene expression.
Yuan W; Collado-Hidalgo A; Yufit T; Taylor M; Varga J
J Cell Physiol; 1998 Oct; 177(1):174-86. PubMed ID: 9731757
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase.
Funeshima N; Fujino M; Kitazawa Y; Hara Y; Hara Y; Hayakawa K; Okuyama T; Kimura H; Li XK
J Gene Med; 2005 May; 7(5):565-75. PubMed ID: 15543532
[TBL] [Abstract][Full Text] [Related]
37. Local expression of indoleamine 2,3-dioxygenase suppresses T-cell-mediated rejection of an engineered bilayer skin substitute.
Forouzandeh F; Jalili RB; Hartwell RV; Allan SE; Boyce S; Supp D; Ghahary A
Wound Repair Regen; 2010; 18(6):614-23. PubMed ID: 20955343
[TBL] [Abstract][Full Text] [Related]
38. A potential role for indoleamine 2,3-dioxygenase (IDO) in Rhodococcus equi infection.
Heller MC; Drew CP; Jackson KA; Griffey S; Watson JL
Vet Immunol Immunopathol; 2010 Dec; 138(3):174-82. PubMed ID: 20739070
[TBL] [Abstract][Full Text] [Related]
39. Acute kidney graft rejection morphology and immunology.
Andersen CB
APMIS Suppl; 1997; 67():1-35. PubMed ID: 9063492
[TBL] [Abstract][Full Text] [Related]
40. Amelioration of rat collagen-induced arthritis through CD4+ T cells apoptosis and synovial interleukin-17 reduction by indoleamine 2,3-dioxygenase gene therapy.
Chen SY; Wu CL; Lai MD; Lin CC; Yo YT; Jou IM; Lee CH; Weng CT; Shiau AL; Wang CR
Hum Gene Ther; 2011 Feb; 22(2):145-54. PubMed ID: 20825285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
